Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Bifidobacterium plantarum

What does the research say about Bifidobacterium plantarum?

14 health outcomes synthesised

Bifidobacterium plantarum has been studied across 14 health outcomes, with the strongest evidence supporting its role in reducing inflammation (8 studies, moderate evidence strength). Research predominantly involves athletes, though effective doses remain unspecified across all outcomes. Other areas of investigation include cognitive function, gut microbiota balance, and immune function, but with lower evidence strength.

Strongest evidence: The best-supported outcome is reduction of inflammation, with 7 of 8 studies showing benefit and a meta-analysis in athletes reporting a moderate reduction in TNF-α (ES=-0.59, p=0.001). Evidence strength is moderate, but the human data are limited to athletes and one neutral review in adults with alcoholic liver disease.

Mixed or weaker evidence: Outcomes such as improved cognitive function (7 studies, all beneficial but low certainty), improved gut microbiota balance (6 reviews, no original trials), and improved immune function (5 reviews, animal/in vitro only) all have low or very low evidence strength. Most syntheses are based on narrative reviews or multi-strain formulas, making the specific effect of Bifidobacterium plantarum uncertain.

Effective dose patterns: No consistent effective dose, form, or duration was reported across any outcome, limiting actionable conclusions.

Population insights: The most studied population is athletes for inflammation. Other outcomes include adults with depression or cognitive impairment, patients with chronic kidney disease, individuals with obesity, and IBS patients. No cross-cutting population pattern emerges.

Notable caveats: Publication bias is a concern across all outcomes—null-result studies are less likely to be indexed. Many syntheses are small (3–8 studies) and rely on review articles rather than primary trials. Effect sizes may be smaller than the predominant direction suggests, and high heterogeneity (e.g., I²=79% for depression) limits confidence.

Frequently asked

  • What is Bifidobacterium plantarum good for according to research?
    Research suggests potential benefits for reducing inflammation (7 of 8 studies beneficial), improving cognitive function (7 of 7 studies beneficial), and supporting gut microbiota balance (6 of 6 studies beneficial). However, evidence strength is moderate only for inflammation; all other outcomes have low or very low evidence.
  • What dose of Bifidobacterium plantarum is typically used in studies?
    No consistent effective dose has been reported across the 12 outcomes. Most syntheses did not extract or report dose, form, or duration data, so no specific dose recommendations can be drawn from the available research.
  • Who benefits most from Bifidobacterium plantarum?
    The strongest evidence comes from studies in athletes, particularly for inflammation reduction. Other populations studied include adults with mild cognitive impairment or depression, patients with chronic kidney disease, and individuals with obesity, but evidence is weaker.
  • Are there caveats or limitations in the research on Bifidobacterium plantarum?
    Yes. Publication bias is a concern across all outcomes. Many studies are narrative reviews or animal experiments, not human trials. The evidence base is small (3–8 studies per outcome) and effect sizes may be inflated. Dosing information is lacking, and several syntheses used multi-strain formulas, making it difficult to isolate Bifidobacterium plantarum's specific effect.
  • Does Bifidobacterium plantarum help with inflammation?
    Seven out of 8 studies reported beneficial effects on inflammation, with a meta-analysis in athletes showing a moderate reduction in TNF-α (ES=-0.59, p=0.001). However, evidence is moderate; one systematic review in adults with alcoholic liver disease found no effect, and many studies are narrative or animal-based.
  • Does Bifidobacterium plantarum help with cognitive function?
    All 7 studies reported beneficial effects on cognitive function, with improvements on the MMSE and MoCA in a meta-analysis (low certainty evidence). However, the evidence is low strength, predominantly from reviews, and no consistent dose or population was identified.

Most-studied combinations with Bifidobacterium plantarum

most supplement research is combination research
Also studied with:Lactobacillus rhamnosus (3), Bifidobacterium lactis UABla-12 (2), Lactobacillus casei rhamnosus (2), Lactobacillus acidophilus LA-02 (2), Lactobacillus rhamnosus HA-500 (2), Lactobacillus rhamnosus HA-114 (2), Bifidobacterium bifidum Rosell-71 (2), Fermented Soy Probiotic (2), Lactobacillus plantarum LP01 (2), Lactobacillus helveticus Rosell-52 (2), Lactobacillus lactis LI-23 (2), Bifidobacterium lactis Bb-02 (2)

  • LactoBif 100 Probiotics

    By California Gold Nutrition

    4.7 (17.7K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $32.35
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top